Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK

Chia Siang Kow; Hamid A. Merchant; Syed Shahzad Hasan

doi:10.1016/j.jinf.2021.05.008

Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK

Chia Siang Kow, Hamid A. Merchant, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e14-e15
Number of pages	2
Journal	Journal of Infection
Volume	83
Issue number	1
Early online date	13 May 2021
DOIs	https://doi.org/10.1016/j.jinf.2021.05.008
Publication status	Published - 1 Jul 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.jinf.2021.05.008Licence: Unspecified

Cite this

@article{f0a1b0f6e529462592bee03410ad9358,

title = "Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK",

keywords = "COVID-19, SARS-CoV-2",

author = "Kow, \{Chia Siang\} and Merchant, \{Hamid A.\} and Hasan, \{Syed Shahzad\}",

note = "Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = jul,

day = "1",

doi = "10.1016/j.jinf.2021.05.008",

language = "English",

volume = "83",

pages = "e14--e15",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK

AU - Kow, Chia Siang

AU - Merchant, Hamid A.

AU - Hasan, Syed Shahzad

N1 - Funding Information: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/7/1

Y1 - 2021/7/1

KW - COVID-19

KW - SARS-CoV-2

UR - https://www.scopus.com/pages/publications/85109115219

U2 - 10.1016/j.jinf.2021.05.008

DO - 10.1016/j.jinf.2021.05.008

M3 - Letter

C2 - 33992685

SN - 0163-4453

VL - 83

SP - e14-e15

JO - Journal of Infection

JF - Journal of Infection

IS - 1

ER -

Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK

UN SDGs

Access to Document

Other files and links

Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials

COVID-19: Patients with mild to moderate infection can now be treated with Japanese antiviral drug

Cite this

Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK

UN SDGs

Access to Document

Other files and links

Research output

Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials

Press/Media

COVID-19: Patients with mild to moderate infection can now be treated with Japanese antiviral drug

Cite this